The Health Care Cost Institute's new study shows insulin costs nearly doubled from 2012 to 2016.
In 2016, patients with Type I diabetes paid, on average, $5,705 for insulin in the U.S., up from $2,864 spent in 2012.
Dr. Joshua D. Miller is a diabetes and endocrinology expert from Stony Brook Medicine with vast experience helping people with diabetes to conquer the challenges of living with the disease. He serves as the Medical Director of Diabetes Care and Assistant Dean for Clinical Integration. He is dual board-certified in Internal Medicine and Endocrinology, Diabetes & Metabolism. He has been living with Type 1 diabetes for more than twenty years. Dr. Miller is the President of The American Diabetes Association Long Island Community Leadership Board, as well as the Project Lead for the Suffolk Care Collaborative’s Diabetes Wellness and Self-Management initiative.
Regarding the Health Care Cost Institute's report, Dr. Miller says:
- Access to affordable insulin remains a public health crisis for people living with all types of diabetes.
- Without insulin, patients with Type 1 diabetes can die. Having to choose between paying for insulin or making a car or mortgage payment is a common occurrence for many of our patients with diabetes.
- Congress needs to act to improve access to this life-sustaining medicine for millions of Americans living with diabetes.
Dr. Miller is available for interview by phone, Skype or live via the VideoLink Studio located on the Stony Brook University campus. To schedule an interview with him, contact Kali Chan, Director of Medicine Media Relations, at 631-487-4092 or Kali.Chan@stonybrookmedicine.edu. Find more experts at Stony Brook University here.